Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study

BACKGROUND: Many older patients have chronic kidney disease (CKD), and a lower dose of anti-depressants paroxetine, mirtazapine and venlafaxine is recommended in patients with CKD to prevent drug accumulation from reduced elimination. Using information available in large population-based healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales: Dev, Varun, Dixon, Stephanie N, Fleet, Jamie L, Gandhi, Sonja, Gomes, Tara, Harel, Ziv, Jain, Arsh K, Shariff, Salimah Z, Tawadrous, Davy, Weir, Matthew A, Garg, Amit X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024017/
https://www.ncbi.nlm.nih.gov/pubmed/24884589
http://dx.doi.org/10.1186/1471-2369-15-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024017/
https://www.ncbi.nlm.nih.gov/pubmed/24884589
http://dx.doi.org/10.1186/1471-2369-15-79

Ejemplares similares